Cases of different subtypes of MS were compared by simultaneous analysis of serum IL-1β, IL-6, IL-8, and TNF-α levels via comparison of two commercially available multiplex platforms (i.e., Luminex-xMAP and Meso Scale Discovery) (108). The gene discussed is IL6; the disease is myeloid sarcoma.